NEXVIAZYME
Live / Registered — Registered (as of 12 Oct 2021)
What this means for you
Registered since 12 Oct 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88318614
- Registration number
- 6521238
- Mark type
- Stylized text
- Filed
- 27 Feb 2019
- Published for opposition
- 28 May 2019
- Registered
- 12 Oct 2021
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
Owner
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 12 Oct 2021 — REGISTERED-PRINCIPAL REGISTER
- 09 Sept 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Sept 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Sept 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Aug 2021 — USE AMENDMENT FILED
- 07 Sept 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Aug 2021 — TEAS STATEMENT OF USE RECEIVED
- 28 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 May 2021 — SOU EXTENSION 4 GRANTED
- 26 May 2021 — SOU EXTENSION 4 FILED
- 26 May 2021 — SOU TEAS EXTENSION RECEIVED
- 09 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Dec 2020 — SOU EXTENSION 3 GRANTED
- 07 Dec 2020 — SOU EXTENSION 3 FILED
- 07 Dec 2020 — SOU TEAS EXTENSION RECEIVED